Emmessar Biotech & Nutrition Ltd.
BSE: 524768
₹23.77
₹0.23
(0.98%)
As on 01-Sep-2026IST
Market cap
₹12 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
30.3
P/B Ratio
1.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
4.2 %
-
ROCE
12.6 %
-
Industry P/E
33.99
-
EV/EBITDA
7.5
-
Debt to Equity
0
-
Book Value
₹16.5
-
EPS
₹0.8
-
Face value
10
-
Shares outstanding
4,996,100
10 Years Aggregate
CFO
₹7.33 Cr
EBITDA
₹-3.98 Cr
Net Profit
₹6.41 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Emmessar Biotech
| -19.0 | -6.2 | -4.0 | -10.3 | -1.6 | -8.5 | 2.8 |
|
BSE Healthcare
| 18.1 | 1.0 | 9.6 | 17.6 | 22.5 | 14.1 | 12.2 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Emmessar Biotech
| -34.2 | 66.1 | -0.9 | -10.3 | 43.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Emmessar Biotech
|
23.8 | 11.9 | 0.3 | 0.4 | -454.0 | 4.9 | 30.3 | 1.4 |
| 6,917.0 | 17,317.8 | 2,432.1 | 169.6 | 8.7 | 20.8 | 102.1 | 19.2 | |
| 2,711.2 | 20,606.4 | 2,287.3 | 678.1 | 31.4 | 19.7 | 31 | 5.5 | |
| 2,033.3 | 12,486.4 | 1,479.1 | 198.6 | 18.6 | 30.3 | 62.7 | 15.5 | |
| 1,299.9 | 17,989.5 | 3,229.7 | 666.9 | 26.6 | 18.8 | 27.9 | 4.4 | |
| 4,665.9 | 21,329.9 | 2,569.8 | 735.2 | 34.4 | 19.2 | 29 | 4.8 | |
| 5,776.0 | 9,598.8 | 1,432.9 | 356.9 | 30.8 | 58.2 | 26.9 | 15.6 | |
| 3,155.0 | 7,254.2 | 1,805.2 | 323.8 | 24.7 | 43.7 | 22.4 | 8.8 | |
| 889.7 | 17,391.1 | 1,682.5 | 273.5 | 21.0 | 11.1 | 58.5 | 6.5 | |
| 1,024.2 | 9,433.0 | 5,004.4 | 635.3 | 14.5 | 19.8 | 15.4 | 2.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Emmessar Biotech
Emmessar Biotech & Nutrition Limited, a healthcare company, manufactures and markets healthcare and nutritional products in India and internationally. It operates through Healthcare, Fine Chemicals, and Rent on Lease Land segments. The company offers... bone care, general health, muscle care, pain relief, sexual health, skin care, and skin cure products. The company was formerly known as Emmessar Chemical Industries Ltd. and changed its name to Emmessar Biotech & Nutrition Limited in April 2000. Emmessar Biotech & Nutrition Limited was founded in 1992 and is headquartered in Mumbai, India. Read more
-
Incorporated
1992
-
Chairman
--
-
Managing Director
Srinivasa Raghavan Mathurakavi Ayyangar
-
Headquarters
Raigad Dist, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Emmessar Biotech
What is the current share price of Emmessar Biotech & Nutrition Ltd Today?
The share price of Emmessar Biotech & Nutrition Ltd is ₹23.77 (BSE) as of 01-Sep-2026 IST. Emmessar Biotech & Nutrition Ltd has given a return of -1.62% in the last 3 years.
What is the current PB & PE ratio of Emmessar Biotech & Nutrition Ltd?
The P/E ratio of Emmessar Biotech & Nutrition Ltd is 30.30 times as on 01-Sep-2026, a 11 discount to its peers’ median range of 33.99 times.
The P/B ratio of Emmessar Biotech & Nutrition Ltd is 1.44 times as on 01-Sep-2026, a 73 discount to its peers’ median range of 5.29 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
48.02 |
1.97 |
2024 |
19.81 |
2.01 |
2023 |
24.59 |
1.86 |
2022 |
28.90 |
2.23 |
2021 |
5.07 |
1.29 |
What is the 52 Week High and Low of Emmessar Biotech & Nutrition Ltd?
The 52-week high and low of Emmessar Biotech & Nutrition Ltd are Rs 42.75 and Rs 18.42 as of 02-Sep-2026.
What is the market cap of Emmessar Biotech & Nutrition Ltd?
Emmessar Biotech & Nutrition Ltd has a market capitalisation of ₹ 12 Cr as on 01-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Emmessar Biotech & Nutrition Ltd?
Before investing in Emmessar Biotech & Nutrition Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.